Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
KUAISHOU-W
01024
5
JD HEALTH
06618
| (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | ---- | -35.47%11.6B | ---- | -10.03%30.32B | ---- | -15.15%17.98B | ---- | -2.57%33.7B | ---- | -15.20%21.19B |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | ---- | -54.82%-35.32M | ---- | -41.42%-98.91M | ---- | -52.85%-22.82M | ---- | 36.61%-69.94M | ---- | 4.74%-14.93M |
| Interest expense - adjustment | ---- | -20.62%1.07B | ---- | -15.26%2.55B | ---- | -16.23%1.34B | ---- | -20.96%3.01B | ---- | -22.50%1.6B |
| Dividend (income)- adjustment | ---- | 0.00%-3.2M | ---- | -58.42%-5.41M | ---- | -1,388.37%-3.2M | ---- | -24.54%-3.42M | ---- | ---215K |
| Attributable subsidiary (profit) loss | ---- | -0.32%-1.23B | ---- | 19.65%-2.55B | ---- | 40.29%-1.23B | ---- | 36.61%-3.18B | ---- | 34.77%-2.06B |
| Impairment and provisions: | ---- | -46.01%178.67M | ---- | 82.43%631.39M | ---- | 503.87%330.93M | ---- | -96.16%346.1M | ---- | -97.14%54.8M |
| -Impairment of property, plant and equipment (reversal) | ---- | -83.57%643K | ---- | -93.30%12.2M | ---- | -75.17%3.91M | ---- | -90.66%182.07M | ---- | -98.87%15.76M |
| -Impairmen of inventory (reversal) | ---- | -59.46%101.74M | ---- | 369.68%444.81M | ---- | 15,863.30%250.94M | ---- | 197.02%94.71M | ---- | -88.86%1.57M |
| -Impairment of trade receivables (reversal) | ---- | ---- | ---- | 561.07%98.84M | ---- | ---- | ---- | -92.68%14.95M | ---- | ---- |
| -Other impairments and provisions | ---- | 0.28%76.29M | ---- | 38.92%75.54M | ---- | 103.03%76.07M | ---- | -99.20%54.37M | ---- | -92.55%37.47M |
| Asset sale loss (gain): | ---- | 114.72%6.71M | ---- | -208.18%-13.46M | ---- | 34.57%3.13M | ---- | 105.03%12.44M | ---- | 133.35%2.32M |
| -Loss (gain) from sale of subsidiary company | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 97.55%-6.17M | ---- | ---- |
| -Loss (gain) on sale of property, machinery and equipment | ---- | 114.72%6.71M | ---- | -172.30%-13.46M | ---- | 34.57%3.13M | ---- | 291.21%18.61M | ---- | 166.87%2.32M |
| Depreciation and amortization: | ---- | 7.36%5.45B | ---- | -7.19%10.43B | ---- | -10.43%5.08B | ---- | 6.12%11.24B | ---- | 8.95%5.67B |
| -Depreciation | ---- | 5.50%4.47B | ---- | -10.76%8.61B | ---- | -12.42%4.24B | ---- | 1.26%9.64B | ---- | 2.22%4.84B |
| -Other depreciation and amortization | ---- | 16.72%983.65M | ---- | 14.41%1.82B | ---- | 1.11%842.74M | ---- | 49.44%1.6B | ---- | 76.29%833.52M |
| Exchange Loss (gain) | ---- | ---- | ---- | -200.87%-25.38M | ---- | ---- | ---- | 1,766.42%25.16M | ---- | 93.20%-899K |
| Operating profit before the change of operating capital | ---- | -27.45%17.04B | ---- | -8.53%41.23B | ---- | -11.21%23.48B | ---- | -14.34%45.08B | ---- | -14.65%26.45B |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | ---- | 284.30%541.4M | ---- | 190.22%679.43M | ---- | 65.48%-293.75M | ---- | 26.76%-753.08M | ---- | -49.68%-850.93M |
| Accounts receivable (increase)decrease | ---- | 70.87%-690.61M | ---- | ---- | ---- | -80.68%-2.37B | ---- | ---- | ---- | 68.74%-1.31B |
| Accounts payable increase (decrease) | ---- | -1,134.75%-3.98B | ---- | -6.32%1.4B | ---- | -54.03%384.73M | ---- | 298.32%1.49B | ---- | 73.29%836.96M |
| Advance payment increase (decrease) | ---- | ---- | ---- | -67.16%3.01B | ---- | ---- | ---- | 63.18%9.15B | ---- | -68.67%1.07B |
| prepayments (increase)decrease | ---- | 72.82%-118.57M | ---- | 128.23%382.31M | ---- | -8.32%-436.25M | ---- | -3,326.80%-1.35B | ---- | 63.28%-402.74M |
| Special items for working capital changes | ---- | -9.33%-2.21B | ---- | -214.73%-5.59B | ---- | 33.32%-2.02B | ---- | 12.67%-1.78B | ---- | 17.28%-3.03B |
| Cash from business operations | ---- | -43.57%10.58B | ---- | -20.70%41.11B | ---- | -17.62%18.75B | ---- | -2.17%51.84B | ---- | -10.24%22.76B |
| Other taxs | ---- | 24.44%-2.91B | ---- | 21.49%-6.97B | ---- | 32.60%-3.86B | ---- | 5.16%-8.87B | ---- | -9.40%-5.72B |
| Adjustment items of business operations | -18.04%21.11B | ---- | -88.95%376.15M | ---- | -9.16%25.76B | ---- | -69.32%3.41B | ---- | -25.02%28.36B | ---- |
| Net cash from operations | -18.04%21.11B | -48.52%7.67B | -88.95%376.15M | -20.54%34.14B | -9.16%25.76B | -12.59%14.89B | -69.32%3.41B | -1.53%42.97B | -25.02%28.36B | -15.34%17.04B |
| Cash flow from investment activities | ||||||||||
| Interest received - investment | ---- | -34.04%612.32M | ---- | -2.16%1.36B | ---- | 31.98%928.35M | ---- | 50.90%1.39B | ---- | 60.54%703.4M |
| Dividend received - investment | -87.82%138.44M | -75.57%67.67M | ---- | -37.31%1.7B | -18.86%1.14B | -62.28%276.97M | -99.17%2.48M | 28.12%2.72B | 2.58%1.4B | -37.26%734.29M |
| Loan receivable (increase) decrease | ---- | -170.09%-2.7B | ---- | 5.65%-3.15B | ---- | 19.60%-998.37M | ---- | -4,050.57%-3.33B | ---- | -204.23%-1.24B |
| Decrease in deposits (increase) | ---- | -236.41%-4.42B | ---- | 232.60%6.05B | ---- | 2,456.32%3.24B | ---- | 111.74%1.82B | ---- | 98.58%-137.43M |
| Sale of fixed assets | 9.51%87.72M | 11.83%87.72M | -98.26%231K | -5.42%53.94M | 191.22%80.11M | 185.34%78.44M | 2,038.06%13.26M | -51.58%57.03M | -74.11%27.51M | -38.74%27.49M |
| Purchase of fixed assets | -44.72%-15.37B | -156.44%-11.15B | -159.82%-5.75B | -61.51%-17.14B | -60.05%-10.62B | -8.03%-4.35B | -6.80%-2.21B | -39.69%-10.61B | -10.66%-6.64B | 9.02%-4.02B |
| Purchase of intangible assets | ---- | 96.47%-108.75M | ---- | 86.66%-928.71M | ---- | -143.90%-3.08B | ---- | -222.56%-6.96B | ---- | -91.31%-1.26B |
| Sale of subsidiaries | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -141.03%-152.63M | ---- | ---- |
| Recovery of cash from investments | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -32.73%10.07M | --10.07M |
| Cash on investment | ---351M | ---- | ---- | ---1M | --0 | ---- | ---- | ---- | ---- | ---- |
| Other items in the investment business | -245.93%-8.11B | ---- | -320.75%-2.49B | -98.73%281K | 74.46%5.56B | ---- | 164.16%1.13B | 15,880.43%22.05M | 127.65%3.19B | -84.60%138K |
| Net cash from investment operations | -514.23%-23.61B | -350.89%-17.6B | -669.26%-8.24B | 19.98%-12.05B | -91.18%-3.84B | 24.79%-3.9B | 69.65%-1.07B | 31.70%-15.06B | 87.50%-2.01B | 56.56%-5.19B |
| Net cash before financing | -111.40%-2.5B | -190.46%-9.94B | -436.78%-7.86B | -20.84%22.09B | -16.82%21.91B | -7.25%10.99B | -69.16%2.33B | 29.28%27.91B | 21.24%26.34B | 44.94%11.84B |
| Cash flow from financing activities | ||||||||||
| New borrowing | 28.70%15.21B | 9.13%11.11B | 34.39%7.9B | -31.43%14.84B | -41.67%11.82B | -37.19%10.19B | -42.51%5.88B | 74.22%21.64B | 168.59%20.26B | 352.47%16.22B |
| Refund | 33.90%-14.33B | 47.65%-7.19B | -8.79%-8.05B | 38.45%-20.72B | 32.62%-21.68B | 38.16%-13.73B | 40.00%-7.4B | -102.42%-33.66B | -64.47%-32.18B | -448.14%-22.2B |
| Issuance of bonds | 139.81%4.8B | --2.8B | --2.8B | --2B | --2B | ---- | ---- | ---- | ---- | ---- |
| Interest paid - financing | ---- | 17.91%-1.04B | ---- | 27.26%-2.4B | ---- | 22.64%-1.26B | ---- | 13.01%-3.3B | ---- | 27.15%-1.63B |
| Dividends paid - financing | 31.94%-7.8B | -49.32%-2.16B | -47.88%-2.31B | -35.22%-13.31B | 6.15%-11.47B | 51.79%-1.44B | 47.56%-1.56B | -120.44%-9.85B | -72.21%-12.22B | -1,030.16%-3B |
| Absorb investment income | -98.18%22.6M | ---- | ---- | 407.98%1.24B | 3,704.56%1.24B | 3,704.56%1.24B | --367.25M | 121.64%243.8M | -70.41%32.55M | -70.41%32.55M |
| Issuance expenses and redemption of securities expenses | ---- | ---4.5B | ---- | -312.50%-5.01B | ---- | ---- | ---- | 87.96%-1.21B | ---- | 95.97%-403.5M |
| Other items of the financing business | 74.90%-93.5M | 95.39%-13.02M | -7.51%-32.13M | ---282.82M | -271.02%-372.47M | ---282.82M | -37.59%-29.89M | ---- | 53.15%-100.39M | ---- |
| Net cash from financing operations | 88.07%-2.2B | 80.60%-1.04B | 110.87%299.15M | 9.21%-23.88B | 23.72%-18.47B | 51.37%-5.37B | 46.25%-2.75B | -15.92%-26.3B | -25.93%-24.21B | 15.31%-11.05B |
| Effect of rate | 197.36%25.99M | -89.75%1.26M | -76.16%2.7M | 200.87%25.38M | 189.00%8.74M | 1,521.02%12.34M | 219.76%11.34M | -1,757.64%-25.16M | -174.75%-9.82M | -94.24%761K |
| Net Cash | -236.40%-4.7B | -295.68%-10.98B | -1,708.71%-7.56B | -210.86%-1.78B | 61.28%3.45B | 608.59%5.61B | -117.07%-418.11M | 246.52%1.61B | -14.74%2.14B | 116.23%791.91M |
| Begining period cash | -5.57%29.82B | -5.57%29.82B | -5.57%29.82B | 5.28%31.58B | 5.28%31.58B | 5.28%31.58B | 5.28%31.58B | -3.53%30B | -3.53%30B | -3.53%30B |
| Cash at the end | -28.22%25.15B | -49.35%18.84B | -28.59%22.26B | -5.57%29.82B | 9.07%35.04B | 20.84%37.21B | -3.89%31.18B | 5.28%31.58B | -4.43%32.13B | 17.39%30.79B |
| Cash balance analysis | ||||||||||
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) | IAS |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- |
| Auditor | -- | -- | -- | Ernst & Young Huaming (Special General Partnership), Ernst & Young | -- | -- | -- | Ernst & Young Huaming (Special General Partnership), Ernst & Young | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.